I was given 1000mg IV infusion of methylprednisolone sodium succinate for my MS. I am coming off 60 months of Tysabri infusions because of 2 allergic reactions. My doctor wants me to go to Copaxene now, but I am 58 with secondary progressive ms. Now, after 4 hours, I am having major issues walking, lips are numbered, major headache, tingling sensation throughout my body, high heart rate, shortness of breath, and blood pressure going up. Should I be concerned?
                                                        
                                                     
                                                    
                                                        
                                                            
                                                            
                                                            
                                                                posted on
                                                            
                                                                Fri, 16 Sep 2016 
                                                            
                                                            
                                                            
                                                            
                                                                
                                                                    
                                                                    
                                                                    Tue, 11 Jun 2019
                                                                    
                                                                    
  Answered on 
                                                                 
                                                                
                                                                    
                                                                    
                                                                    Wed, 12 Jun 2019
                                                                    
                                                                    
  Last reviewed on